hotspot -WSS

hotspot

author：leisure time 2025-09-03 05:27:25 - browse：836

insulin biosimilar — The suit, filed in a Texas federal court by the American Clinical Laboratory Association and PCR lab HealthTrackRx, claims the FDA does not have the authority to scrutinize lab-developed tests. Jacquelyn Martin/AP

A group representing clinical labs across the country sued the Food and Drug Administration on Wednesday over the agency’s plan to actively regulate lab-developed tests.

The suit, filed in a Texas federal court by the American Clinical Laboratory Association and PCR lab HealthTrackRx, claims the FDA does not have the authority to scrutinize lab-developed tests. When the FDA finalized its test regulation plan last month, several experts said it was only a matter of time until someone in the lab industry sued.

Tests made in labs have historically gone unregulated by the FDA, as the agency considered them low-risk when it started regulating medical devices in 1976. But the tests have since become more numerous and complex, and the regulatory gray area enabled unreliable tests to thrive and harm patients. Infamous examples include Theranos’ blood tests, as well as misleading prenatal genetic tests from a range of companies.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Medicare drug price lawsuits could be good politics for Biden

WSS

Immunocompromised patients offer clues on chronic Covid

Printout prescription drug information shouldn’t go digital

A pediatrician calls for Congress to pass the child tax credit deal

Police still searching for prisoner who escaped from NYC hospital

What to know about Virgin Galactic's 1st mission taking paying customers to space

In same hospitals, Black patients receive fewer opioids than white patients

knowledge

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

entertainment

Activists slam private health insurers over coverage restrictions

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

Peter Hotez and the public health issue of online harassment

South Korea throws huge K

Psychedelics group wrestles with new pharma identity

Medicare bonuses could stop drug shortages under Senate plan

Hollywood unions extend contract negotiations for actors

FDA endorses new sterilization method for medical devices

Hollywood unions extend contract negotiations for actors

Dana Farber says 6 studies to be retracted and 31 corrected

entertainment

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

Naloxone nonprofit donates 200,000 doses after FDA approval

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

Prior authorization reform is both possible and imperative

Police still searching for prisoner who escaped from NYC hospital

Inaction leaves children at risk from dangerous chemotherapy drug

focus

hotspot

entertainment

hotspot